A focus on new treatment methods
Dr. Madelon Vollebregt
Senior researcher, with Brainclinics since January 2016
Where did you study?
I graduated at the Radboud University Nijmegen as Neuropsychologist and Cognitive Neuroscientist. In both fields, I gained a Master degree (in 2010 and 2012 respectively). In my subsequent PhD-trajectory at the Donders Institute, in cooperation with Karakter child- and adolescent psychiatry, I focused on the development of potential new treatment methods for children with ADHD. Among other things, I investigated the efficacy of EEG-neurofeedback treatment in children with ADHD in a blinded placebo-controlled manner. Furthermore, I investigated ‘alpha’ brainwaves during attentional task performance. Its results opened up doors towards the development of innovative treatments for children with ADHD. In 2016 I received my PhD.
What do you do?
I work as a senior researcher at Research Institute Brainclinics and am also still affiliated to the Donders Institute. In the near future, I will mainly focus on the investigation of ‘personalized medicine’ in ADHD. Currently I am also preparing a book about sleep, which will be published through Brainclinics Insights.
Research Institute Brainclinics
6524 AD Nijmegen, The Netherlands
Tel: +31 (0)24-7503505
Fax: +31 (0)84-2206116